CN107141336A - 具有dpp‑iv抑制活性的牦牛骨蛋白肽及制备方法 - Google Patents
具有dpp‑iv抑制活性的牦牛骨蛋白肽及制备方法 Download PDFInfo
- Publication number
- CN107141336A CN107141336A CN201710345026.3A CN201710345026A CN107141336A CN 107141336 A CN107141336 A CN 107141336A CN 201710345026 A CN201710345026 A CN 201710345026A CN 107141336 A CN107141336 A CN 107141336A
- Authority
- CN
- China
- Prior art keywords
- yak bone
- bone protein
- yak
- protein peptide
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 143
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 130
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 126
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 126
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 title claims abstract description 55
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 title claims abstract description 52
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 108091005804 Peptidases Proteins 0.000 claims abstract description 55
- 239000004365 Protease Substances 0.000 claims abstract description 55
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 44
- 235000019419 proteases Nutrition 0.000 claims abstract description 44
- 150000001875 compounds Chemical class 0.000 claims abstract description 36
- 230000003064 anti-oxidating effect Effects 0.000 claims abstract description 13
- 239000003513 alkali Substances 0.000 claims abstract description 12
- 239000000796 flavoring agent Substances 0.000 claims abstract description 12
- 235000019634 flavors Nutrition 0.000 claims abstract description 12
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims description 70
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 40
- 238000000926 separation method Methods 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000001976 enzyme digestion Methods 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 238000004108 freeze drying Methods 0.000 claims description 15
- 238000004007 reversed phase HPLC Methods 0.000 claims description 15
- 239000012528 membrane Substances 0.000 claims description 14
- 239000000499 gel Substances 0.000 claims description 13
- 229920001184 polypeptide Polymers 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- 102000035195 Peptidases Human genes 0.000 claims description 11
- 239000003480 eluent Substances 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 9
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 9
- 238000005238 degreasing Methods 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 229920005654 Sephadex Polymers 0.000 claims description 7
- 239000012507 Sephadex™ Substances 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000029087 digestion Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 230000003647 oxidation Effects 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 230000001629 suppression Effects 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 239000012043 crude product Substances 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims 1
- 238000004128 high performance liquid chromatography Methods 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 239000003112 inhibitor Substances 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 2
- 239000002417 nutraceutical Substances 0.000 abstract description 2
- 235000021436 nutraceutical agent Nutrition 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- 230000031700 light absorption Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- -1 DPPH Free radical Chemical class 0.000 description 5
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 239000000919 ceramic Substances 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 239000002893 slag Substances 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HCEQQASHRRPQFE-UHFFFAOYSA-N 5-chloro-n-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide;3-(diaminomethylidene)-1,1-dimethylguanidine;hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N.COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 HCEQQASHRRPQFE-UHFFFAOYSA-N 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 229940112611 glucovance Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 description 1
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229940122355 Insulin sensitizer Drugs 0.000 description 1
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 1
- LLBQJYDYOLIQAI-JYJNAYRXSA-N Leu-Glu-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LLBQJYDYOLIQAI-JYJNAYRXSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000007516 brønsted-lowry acids Chemical class 0.000 description 1
- 150000007528 brønsted-lowry bases Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000018791 negative regulation of catalytic activity Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 1
- 229960004034 sitagliptin Drugs 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710345026.3A CN107141336B (zh) | 2017-05-16 | 2017-05-16 | 具有dpp-iv抑制活性的牦牛骨蛋白肽及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710345026.3A CN107141336B (zh) | 2017-05-16 | 2017-05-16 | 具有dpp-iv抑制活性的牦牛骨蛋白肽及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107141336A true CN107141336A (zh) | 2017-09-08 |
CN107141336B CN107141336B (zh) | 2020-06-12 |
Family
ID=59778071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710345026.3A Active CN107141336B (zh) | 2017-05-16 | 2017-05-16 | 具有dpp-iv抑制活性的牦牛骨蛋白肽及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107141336B (zh) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108314705A (zh) * | 2018-01-26 | 2018-07-24 | 海普诺凯营养品有限公司 | 具有dpp-iv抑制功能的羊乳清蛋白肽、其制备方法及其应用 |
CN108342441A (zh) * | 2018-02-27 | 2018-07-31 | 国肽生物工程(常德)有限公司 | 一种缓解疲劳和抗氧化的牦牛骨蛋白肽及制备方法 |
CN108841905A (zh) * | 2018-06-21 | 2018-11-20 | 国肽生物工程(常德)有限公司 | 一种具有ace抑制和抗疲劳功能的蜂蛹蛋白肽及其制备方法 |
CN108893512A (zh) * | 2018-07-09 | 2018-11-27 | 青海国肽生物科技有限公司 | 一种具有dpp-ⅳ抑制和抗疲劳功能的蜂蛹蛋白肽及其制备方法 |
CN109295140A (zh) * | 2018-10-22 | 2019-02-01 | 浙江海洋大学 | 一种日本黄姑鱼鱼鳔胶原蛋白源二肽基肽酶-iv抑制肽的制备方法 |
CN110669813A (zh) * | 2019-10-28 | 2020-01-10 | 山西原生肽科技有限公司 | 一种牦牛肋骨小分子肽及其提取方法 |
CN110923285A (zh) * | 2019-12-12 | 2020-03-27 | 陶红梅 | 牛骨肽及其制备工艺 |
CN111635920A (zh) * | 2020-05-21 | 2020-09-08 | 内蒙古元本生物医药科技有限公司 | 一种二级仿生酶解技术制备驴骨胶原蛋白肽粉的方法 |
CN112225796A (zh) * | 2020-10-12 | 2021-01-15 | 江南大学 | 一种具有dpp-iv抑制活性的羊皮胶原蛋白肽及其制备方法 |
CN112569347A (zh) * | 2020-12-30 | 2021-03-30 | 青海瑞肽生物科技有限公司 | 牦牛胶原蛋白肽在降血糖药物或降血糖保健食品中的应用 |
CN112741203A (zh) * | 2021-01-19 | 2021-05-04 | 西南民族大学 | 一种肝磷酸化肽的制备方法、肝磷酸化肽、抗氧化肉制品及制备方法 |
CN113087773A (zh) * | 2021-04-29 | 2021-07-09 | 安徽国肽生物科技有限公司 | 一种具有降血糖和抗氧化功能的牦牛骨肽及其制备方法 |
CN113144169A (zh) * | 2021-02-10 | 2021-07-23 | 渤海大学 | 一种黄嘌呤氧化酶抑制肽及其应用 |
CN113151386A (zh) * | 2021-04-16 | 2021-07-23 | 安徽国肽生物科技有限公司 | 具有dpp-iv抑制功能的牡蛎肽及其制备方法和应用 |
CN113201065A (zh) * | 2021-04-19 | 2021-08-03 | 国肽生物工程(常德)有限公司 | 一种具有缓解疲劳和改善骨密度功能的牛骨胶原蛋白肽及其制备方法 |
CN113215212A (zh) * | 2021-04-16 | 2021-08-06 | 国肽生物工程(常德)有限公司 | 一种具有抗氧化和ace抑制功能的大豆蛋白肽及其制备方法 |
CN113480605A (zh) * | 2021-07-27 | 2021-10-08 | 中国海洋大学 | 一种牦牛乳酪蛋白dpp-iv抑制肽及其筛选方法 |
CN114349849A (zh) * | 2021-12-23 | 2022-04-15 | 华南理工大学 | 一种具有降血糖功效的胶原蛋白酶解物及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101418037A (zh) * | 2008-11-14 | 2009-04-29 | 华子昂 | 一种牦牛骨肽及其制备方法 |
CN106520874A (zh) * | 2016-11-07 | 2017-03-22 | 中国农业大学 | 一种具有降血糖和抗氧化功能的鱼鳔蛋白肽及其制备方法 |
-
2017
- 2017-05-16 CN CN201710345026.3A patent/CN107141336B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101418037A (zh) * | 2008-11-14 | 2009-04-29 | 华子昂 | 一种牦牛骨肽及其制备方法 |
CN106520874A (zh) * | 2016-11-07 | 2017-03-22 | 中国农业大学 | 一种具有降血糖和抗氧化功能的鱼鳔蛋白肽及其制备方法 |
Non-Patent Citations (3)
Title |
---|
ASSAAD SILA,等: "Purification, identification and structural modelling of DPP-IV inhibiting peptides from barbel protein hydrolysate", 《JOURNAL OF CHROMATOGRAPHY B》 * |
冯美卿: "《生物技术制药》", 31 January 2016 * |
张立宏,等: "二肽基肽酶-Ⅳ抑制剂药理学作用及机制的研究进展", 《中国新药杂志》 * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108314705A (zh) * | 2018-01-26 | 2018-07-24 | 海普诺凯营养品有限公司 | 具有dpp-iv抑制功能的羊乳清蛋白肽、其制备方法及其应用 |
CN108314705B (zh) * | 2018-01-26 | 2020-07-14 | 海普诺凯营养品有限公司 | 具有dpp-iv抑制功能的羊乳清蛋白肽、其制备方法及其应用 |
CN108342441A (zh) * | 2018-02-27 | 2018-07-31 | 国肽生物工程(常德)有限公司 | 一种缓解疲劳和抗氧化的牦牛骨蛋白肽及制备方法 |
CN108841905A (zh) * | 2018-06-21 | 2018-11-20 | 国肽生物工程(常德)有限公司 | 一种具有ace抑制和抗疲劳功能的蜂蛹蛋白肽及其制备方法 |
CN108893512A (zh) * | 2018-07-09 | 2018-11-27 | 青海国肽生物科技有限公司 | 一种具有dpp-ⅳ抑制和抗疲劳功能的蜂蛹蛋白肽及其制备方法 |
CN109295140A (zh) * | 2018-10-22 | 2019-02-01 | 浙江海洋大学 | 一种日本黄姑鱼鱼鳔胶原蛋白源二肽基肽酶-iv抑制肽的制备方法 |
CN109295140B (zh) * | 2018-10-22 | 2022-01-18 | 浙江海洋大学 | 一种日本黄姑鱼鱼鳔胶原蛋白源二肽基肽酶-iv抑制肽的制备方法 |
CN110669813A (zh) * | 2019-10-28 | 2020-01-10 | 山西原生肽科技有限公司 | 一种牦牛肋骨小分子肽及其提取方法 |
CN110923285A (zh) * | 2019-12-12 | 2020-03-27 | 陶红梅 | 牛骨肽及其制备工艺 |
CN110923285B (zh) * | 2019-12-12 | 2021-04-16 | 安徽盛美诺生物技术有限公司 | 牛骨肽及其制备工艺 |
CN111635920A (zh) * | 2020-05-21 | 2020-09-08 | 内蒙古元本生物医药科技有限公司 | 一种二级仿生酶解技术制备驴骨胶原蛋白肽粉的方法 |
CN112225796A (zh) * | 2020-10-12 | 2021-01-15 | 江南大学 | 一种具有dpp-iv抑制活性的羊皮胶原蛋白肽及其制备方法 |
CN112569347A (zh) * | 2020-12-30 | 2021-03-30 | 青海瑞肽生物科技有限公司 | 牦牛胶原蛋白肽在降血糖药物或降血糖保健食品中的应用 |
CN112569347B (zh) * | 2020-12-30 | 2023-09-22 | 青海瑞肽生物科技有限公司 | 牦牛胶原蛋白肽在降血糖药物或降血糖保健食品中的应用 |
CN112741203A (zh) * | 2021-01-19 | 2021-05-04 | 西南民族大学 | 一种肝磷酸化肽的制备方法、肝磷酸化肽、抗氧化肉制品及制备方法 |
CN113144169A (zh) * | 2021-02-10 | 2021-07-23 | 渤海大学 | 一种黄嘌呤氧化酶抑制肽及其应用 |
CN113144169B (zh) * | 2021-02-10 | 2023-05-30 | 渤海大学 | 一种黄嘌呤氧化酶抑制肽及其应用 |
CN113151386A (zh) * | 2021-04-16 | 2021-07-23 | 安徽国肽生物科技有限公司 | 具有dpp-iv抑制功能的牡蛎肽及其制备方法和应用 |
CN113215212A (zh) * | 2021-04-16 | 2021-08-06 | 国肽生物工程(常德)有限公司 | 一种具有抗氧化和ace抑制功能的大豆蛋白肽及其制备方法 |
CN113151386B (zh) * | 2021-04-16 | 2022-08-16 | 安徽国肽生物科技有限公司 | 具有dpp-iv抑制功能的牡蛎肽及其制备方法和应用 |
CN113201065A (zh) * | 2021-04-19 | 2021-08-03 | 国肽生物工程(常德)有限公司 | 一种具有缓解疲劳和改善骨密度功能的牛骨胶原蛋白肽及其制备方法 |
CN113201065B (zh) * | 2021-04-19 | 2022-05-20 | 国肽生物工程(常德)有限公司 | 一种具有缓解疲劳和改善骨密度功能的牛骨胶原蛋白肽及其制备方法 |
CN113087773B (zh) * | 2021-04-29 | 2022-02-18 | 安徽国肽生物科技有限公司 | 一种具有降血糖和抗氧化功能的牦牛骨肽及其制备方法 |
CN113087773A (zh) * | 2021-04-29 | 2021-07-09 | 安徽国肽生物科技有限公司 | 一种具有降血糖和抗氧化功能的牦牛骨肽及其制备方法 |
CN113480605A (zh) * | 2021-07-27 | 2021-10-08 | 中国海洋大学 | 一种牦牛乳酪蛋白dpp-iv抑制肽及其筛选方法 |
CN114349849A (zh) * | 2021-12-23 | 2022-04-15 | 华南理工大学 | 一种具有降血糖功效的胶原蛋白酶解物及其制备方法和应用 |
CN114349849B (zh) * | 2021-12-23 | 2023-08-04 | 华南理工大学 | 一种具有降血糖功效的胶原蛋白酶解物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN107141336B (zh) | 2020-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107141336A (zh) | 具有dpp‑iv抑制活性的牦牛骨蛋白肽及制备方法 | |
CN108342441B (zh) | 一种缓解疲劳和抗氧化的牦牛骨蛋白肽及制备方法 | |
CN107164445B (zh) | 具有dpp-ⅳ抑制功能的鱼皮蛋白肽及其制备方法与应用 | |
CN106520874A (zh) | 一种具有降血糖和抗氧化功能的鱼鳔蛋白肽及其制备方法 | |
US8940685B2 (en) | Method for preparing active peptides from corn germ proteins | |
CN100999752B (zh) | 一种源自胶原蛋白的抗氧化肽混合物及其制备方法和用途 | |
AU666531B2 (en) | Processes for the preparation of amylase inhibitor | |
CN107164444A (zh) | 具有抗氧化功能的鱼皮蛋白肽及其制备方法与应用 | |
CN108935912B (zh) | 一种具有dpp-ⅳ抑制和抗疲劳功能的鱼肉蛋白肽及其制备方法 | |
CN113215212A (zh) | 一种具有抗氧化和ace抑制功能的大豆蛋白肽及其制备方法 | |
CN108314705B (zh) | 具有dpp-iv抑制功能的羊乳清蛋白肽、其制备方法及其应用 | |
CN111269290B (zh) | 一种鲟鱼抗炎肽的制备方法 | |
Li et al. | Purification, characterization, synthesis, in vivo and in vitro antihypertensive activity of bioactive peptides derived from coconut (Cocos nucifera L.) cake globulin hydrolysates | |
CN107082807A (zh) | 具有ace抑制功能的牦牛骨蛋白肽及制备方法和应用 | |
CN101590223B (zh) | 一种sod复合胶囊及其制备方法 | |
CN113248567B (zh) | 一种苦味受体阻滞肽及其应用 | |
CN107828842B (zh) | 一种具有抗氧化和dpp-iv抑制功能的核桃蛋白肽 | |
CN115960165B (zh) | 一种来源于辣木叶的富硒ace抑制肽及其应用 | |
CN109810177A (zh) | 一种具有ace抑制活性的核桃粕多肽及其制备方法和应用 | |
CN108893512B (zh) | 一种具有dpp-ⅳ抑制和抗疲劳功能的蜂蛹蛋白肽及其制备方法 | |
Sandate-Flores et al. | Biofunctional properties of the bioactive peptide from protein isolates of jiotilla (Escontria chiotilla) and pitaya (Stenocereus pruinosus) seeds | |
CN107699601A (zh) | 一种具有ace抑制功能和dpp‑iv抑制功能的蛹虫草蛋白肽 | |
CN102787154A (zh) | 一种乌鸡低聚肽的制备及其活性肽段分离、鉴定方法 | |
KR20080034712A (ko) | 대두 발효 조성물의 제조방법 및 이 조성물 | |
KR100787949B1 (ko) | 대두 발효 조성물의 제조방법 및 이 조성물로부터 유래된펩타이드 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190116 Address after: 242100 Langxi County Economic Development Zone, Xuancheng, Anhui Applicant after: Anhui peptide Biotechnology Co., Ltd. Address before: 810003 incubator building of Xining Biological Park via No. 26, Fourth Road, Qinghai Province Applicant before: Qinghai peptide Biotechnology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210830 Address after: 100006 a611f, 99 Wangfujing Street, Dongcheng District, Beijing Patentee after: People's peptide Group Co.,Ltd. Address before: 242100 Langxi Economic Development Zone, Anhui, Xuancheng Patentee before: ANHUI GUOTAI BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |